Industrial-Scale Production of Human Pluripotent Stem Cells Using Novel Media and Bioreactors
Reference number | |
Coordinator | Lancell AB |
Funding from Vinnova | SEK 1 000 000 |
Project duration | November 2024 - October 2025 |
Status | Ongoing |
Venture | Utlysning Infrastruktur for the development of accurate drug treatment |
Call | Use infrastructures to develop precision medicine |
Purpose and goal
The aim is to test Lancell AB´s patented human pluripotent stem cel media in new innovative bioreactors that have not previously been used for human pluripotent stem cell production. The goal is to create a solution for stem cell culture that is significantly more effective and cost-effective than existing options.